#Paris #France #GLP-1 #Havas Health #Shape Shifting

Havas Health Network Unveils Innovative GLP-1 Consultancy

On March 13, Havas Health Network will launch its new GLP-1 consultancy in Paris during an event titled 'Shape Shifting: A Close Look at the Health and Wellness Disruptor – GLP-1'. This gathering is designed to bring together thought leaders, industry professionals, and brand experts to discuss the transformative potential of GLP-1 treatments across the European landscape.

Inspired by last November's successful GLP101 Day held in New York, the Paris event aims to delve deeper into the scientific advancements behind GLP-1 and explore its substantial impact on healthcare and consumer markets. As obesity and diabetes continue to surge in high-income nations, the demand for these treatments is burgeoning, with projections forecasting a global market of approximately $5.56 billion by 2030. This growth is a result of both new drug launches and an increasing need for innovative solutions in the face of rising health challenges.

Chloé Depiesse, the General Manager of Havas Health Network, shared her thoughts on the unique cultural nuances between North American and European markets that influence the adoption and engagement with GLP-1 treatments beyond just medical contexts. “Understanding European insights allows us to refine our approach and cater to local needs, keeping us ahead in this rapidly evolving sector,” she remarked.

Furthermore, Anna Maria Marra, the CEO for Europe at Havas Health Network, emphasized their commitment to using their robust network and knowledge in the evolving GLP-1 sphere to introduce innovative solutions that meet emerging market demands effectively. “Our aim is to engage and educate clients and partners about GLP-1 treatments and their expanding applications throughout Europe,” Marra added.

The event will undoubtedly become a pivotal point in recognizing how GLP-1 is not only reshaping healthcare paradigms but influencing consumer behavior and lifestyle changes regarding health and wellness.

Havas Health Network’s longstanding dedication to merging creativity with technology and health is evident through this event as well as their overall strategy. By offering insights and actionable information to European marketing leaders, Havas continues to foster growth and innovation within the healthcare industry.

For more information about Havas Health Network's GLP-1 consultancy and how to navigate this new landscape, visit their website. Additionally, be sure to check out Havas's proprietary GLP-1 Consumer Insights report for a comprehensive overview of this thriving sector.

In an industry that is constantly evolving, Havas Health Network stands out as a trailblazer, ready to meet the needs of clients eager to capitalize on the rapid advancements and implications of GLP-1 therapies across Europe and beyond.

About Havas Health Network

Havas Health Network encompasses several health and communications networks, including Havas Life, Havas Lynx, and Jacques. Their concentration on making a significant impact through talent, tenacity, and technology reinforces their pivotal role in supporting companies, brands, and people operating within the health sector.

For press inquiries, you can reach out to:

• - Payton Green, Vice President of Global Communications
• - Sahra Brault, Account Director, Havas Life Paris

Stay tuned for further developments as Havas Health Network continues to push boundaries and redefine health consultancy with the advent of dynamic solutions like those presented at the 'Shape Shifting' event.